UPS moves deeper into cold chain with Marken acquisition

London, UK: UPS is to purchase Marken which will remain self-operating as a wholly owned subsidiary of UPS.

Marken services 49,000 clinical trial sites and its acquisition is part of a string of UPS investments and acquisitions in clinical trial logistics for drug and vaccine research.

UPS is upgrading it capability to move temperature-sensitive biological specimens in and out of more than 60 countries. With the new acquisition, UPS is looking to gain market share over FedEx and DHL, which currently dominate the market.

The high-risk, high-need nature of clinical trial and healthcare logistics makes the service a profitable venture. The losses associated with temperature-excursions in healthcare are estimated at $35 billion.

Marken’s position as a clinical trial logistics provider will help UPS break into a competitive market, since healthcare shippers place a premium on brand-reliability. Simply, as more companies outsource their clinical trials through academic partnerships or ventures, using a well-known shipper avoids logistics liabilities and consequent disputes.

WORLD NEWS

Transfrigoroute International to hold AGM in Italy

Naples, Italy: Transfrigoroute International is holding its annual general meeting in Naples on 26-27 September. Transfrigoroute International president Umberto Torello says that the AGM will …

READ THE FULL STORY >

Denmark’s DSV acquires Panalpina

Copenhagen, Denmark: Denmark’s DSV has completed the acquisition of Swiss logistics group Panalpina, creating the world’s fourth largest freight-forwarding company. The combination of DSV and …

READ THE FULL STORY >

New controlled environment construction firm launches

Trabuco Canyon, California, USA: Vince Free has set up Freez Construction, a thermal contracting firm. Freez Construction builds “cold storage thermal envelopes within the controlled environment …

READ THE FULL STORY >

Walmart to spend $1.2bn to upgrade logistics in China

Dongguan, China: Walmart has pledged to spend around $1.2bn to build or upgrade more than 10 distribution centres in China over the next 10-20 years. …

READ THE FULL STORY >

WHAT’S ON

  • Pharma and Biosciences Conference
    The Cool Chain Association Pharma and Biosciences Conference takes place on 23-24 September 2019 in Paris. Contact: www.caasint.com

Latest Tweets

Watch out for Cold Chain News' guide to UK and Irish coldstores in our September issue... twitter.com/theloadstar/st…

© 2019 Global Cold Chain News | Terms of use | Privacy Policy
Commercial Transport Publishing Limited, registered in England and Wales, Company No: 6453302. Registered Office: 6 Corunna Court, Corunna Road, Warwick CV34 5HQ